RNU4ATAC7P

Across TCGA pan-cancer cohorts, RNU4ATAC7P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU4ATAC7P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU4ATAC7P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU4ATAC7P expression acts as an unfavorable survival marker.

BLCA, UCEC, and BRCA are the cancer types where RNU4ATAC7P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	III,IV	0.381	0.657	<.001	69	view →
UCEC	OS	Tertile	All	0.518	0.928	<.001	36	view →
BRCA	DFS	Tertile	II,III,IV	0.720	0.942	.010	12	view →
STAD	DFS	Tertile	All	0.479	0.666	.026	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU4ATAC7P–BLCA (OS)

Open the BLCA breakdown →